All
Novel Agents, Including Immunotherapy, Look to Conquer Advanced Liver Cancer
April 27th 2016A number of novel therapies are currently being explored as second-line treatments for patients with advanced hepatocellular carcinoma (HCC), including a host of targeted therapies and various immune checkpoint inhibitors.